Global Cell Culture Products Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 2,500.00 Million |
 Market Size (Forecast Year) |
USD 7,000.00 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球细胞培养产品市场、产品（消耗品、设备）、细胞培养应用（生物制药/治疗学、干细胞技术、癌症研究、药物筛选和开发、组织工程和再生医学等）、最终用户（制药和生物技术公司、医院和诊断实验室、研究机构、细胞库）——行业趋势和预测到 2030 年。
细胞培养产品市场分析和规模
细胞培养是指在自然环境之外的某些受控条件下培养细胞。一旦将目标细胞从活组织中分离出来，就可以在严格控制的条件下进行培养。基因表达技术的最新发展使得新型疫苗和生物制药的生产成为可能，从而增加了细胞培养技术的研发应用。此外，癌症研究项目的增加和基因疗法应用范围的扩大预计将推动市场的发展。
Data Bridge Market Research 分析，细胞培养产品市场规模在 2022 年为 25 亿美元，到 2030 年将飙升至 70 亿美元，预计在预测期内的复合年增长率为 12.00%。这表明了市场价值。由于对细胞培养基的需求不断增长，消耗品在细胞培养产品市场的产品领域占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
细胞培养产品市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）和定价（美元） |
|
涵盖的领域 |
产品（消耗品、设备）、细胞培养应用（生物制药/治疗学、干细胞技术、癌症研究、药物筛选和开发、组织工程和再生医学等）、最终用户（制药和生物技术公司、医院和诊断实验室、研究机构、细胞库） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), HiMedia Laboratories (India), Avantor, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Sartorius AG (Germany), Corning Incorporated (U.S.), Lonza Group Ltd. (Switzerland), Evonik (Germany),and Cell Rev (U.K) among others |
|
Market Opportunities |
|
Market Definition
Cell biology warrants in-depth research into its various facets, such as stem cell and gene therapy. Manufacturers must invest in high-quality equipment and other inputs to develop high-end products that adhere to high regulatory standards. This limits the accessibility of smaller enterprises to the priced cell culture resources. The same applies to research institutes with limited capacities. Even further in the processing steps, manufacturers must invest time and technical expertise for cell harvesting.
Global Cell Culture Products Market Dynamics
Drivers
- Rising Preference for Cell-based Vaccines Surges Product Demand
The threat of virus outbreaks has created a lucrative market for vaccines globally. However, this has also led to the demand for highly efficient vaccine variants. Hence, the pharm industry has adopted cell culture extensively for developing vaccines. Cell culture finds application in developing various vaccines for rotavirus, polio, rubella, hepatitis, and chickenpox. Developed nations are significantly developing a penchant for cell-based vaccines. This has eased regulatory processes of cell-based vaccine approval in these regions. Moreover, there is growing awareness about the many benefits of cell culture vaccines.
- Research and development proficiencies
Rising expenditure for research and development proficiencies, especially in developed and developing economies about medical drugs will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop medical instruments are also expected to drive the market growth rate.
- Cutting-edge Solutions for Treatment Bolster Market Prospects
The cell culture market is currently expanding due to innovations. Various biotech and pharmaceutical companies are investing heavily in cell culture research and development. Hence, the demand for advanced cell culture product variants is rising. Similarly, there is an increasing need for novel therapeutics like biosimilars that positively impact market prospects.
Opportunities
Furthermore, an upsurge in the public-private funding for target research activities, rising demand for chronic diseases treatments using advanced drugs, and rising product innovations and development owing to technological advancements worldwide will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, the rising internet penetration rate, increasing adoption of cell media, rise in healthcare products globally, and increasing per capita expenditure on healthcare will further expand the market's growth rate.
Restraints/Challenges
On the other hand, high costs associated with research and development proficiencies, limited infrastructural facilities, high costs associated with medicine, and a shortage of awareness in backward economies are expected to obstruct market growth. Also, the lack of favorable reimbursement scenarios and technology penetration in developing economies, the heavy customs duty imposed on medical devices, and the lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.
This Cell Culture Products market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Cell Culture Products market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In June 2022, Evonik launched the cQrex portfolio of cell culture ingredients to increase efficiency and productivity in bioprocesses for producing monoclonal antibodies, vaccines, viral vectors, and therapeutic cells
- In February 2022, CellulaREvolution raised GBP 1.75 million to accelerate the launch of its continuous cell culture technology
Global Cell Culture Products Market Scope
细胞培养产品市场根据产品类型、细胞培养应用和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
产品
- 耗材
- 设备
细胞培养应用
- 生物制药/治疗学
- 干细胞技术
- 癌症研究
- 药物筛选与开发
- 组织工程
- 再生医学
- 其他的
最终用户
- 制药和生物技术公司
- 医院和诊断实验室
- 研究机构
- 细胞库
全球细胞培养产品市场区域分析/见解
对全球细胞培养产品市场进行了分析，并按国家、类型、价格范围、应用和最终用户提供了市场规模见解和趋势。
细胞培养产品市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
北美有望主导细胞培养产品市场，因为该地区拥有强大的医疗设施基础、主要市场参与者的强大影响力、慢性病病例的增加以及研究活动数量的增加。
预计亚太地区将在 2023 年至 2030 年的预测期内出现显著增长，这得益于政府加强宣传力度、医疗旅游业兴起、该地区研究活动增多、有大量未开发市场、人口众多以及对优质医疗服务的需求不断增长。
报告的国家部分还提供了影响单个市场影响因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。
医疗保健基础设施增长安装基础和新技术渗透
细胞培养产品市场还为您提供详细的市场分析，包括每个国家/地区资本设备医疗保健支出的增长、细胞培养产品市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对细胞培养产品市场的影响。数据适用于 2015-2020 年的历史时期。
竞争格局和细胞培养产品市场份额分析
细胞培养产品市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
细胞培养产品市场的一些主要参与者包括：
- 赛默飞世尔科技公司（美国）
- 默克集团（德国）
- HiMedia 实验室（印度）
- Avantor, Inc.（美国）
- 富士胶片控股株式会社（日本）
- 安捷伦科技公司（美国）
- Sartorius AG（德国）
- 康宁公司（美国）
- 龙沙集团有限公司 (瑞士)
- 赢创 (德国)
- Cell Rev（英国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
